載入中
NASDAQFinancial ServicesFinancial - Conglomerates
最新資料
US$0.07
+US$0.0051 · +7.86%
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
前收盤價
US$0.07
+US$0.0051 · +7.86%
盤中時間採用ET。市場資料可能有所延遲。
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
日內區間
目前US$0.07
52週區間
目前US$0.07
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
持有
估值
85
深度低估
情緒
58
多空交錯
風險
59
風險偏高
動能
25
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
日內區間
目前US$0.07
52週區間
目前US$0.07
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 |
|---|---|---|
| 銷售、一般及管理費用 | 130.05萬 USD | 15.17萬 USD |
| 營業費用 | 130.05萬 USD | 15.17萬 USD |
| 利息收入 | 493.38萬 USD | — |
| 營業利益 | −130.05萬 USD | −15.17萬 USD |
| 淨利 | 418.71萬 USD | −15.17萬 USD |
公司資料更新於 2026年10月11日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
